Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $751.1300 (-1%) ($751.1300 - $751.1300) on Wed. Mar. 22, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.73% (three month average) | RSI | 42 | Latest Price | $751.1300(-1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN declines -1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(48%) XLV(43%) DIA(33%) VYM(29%) SPLV(28%) | Factors Impacting REGN price | REGN will decline at least -0.865% in a week (0% probabilities). VXX(-24%) VIXM(-15%) UUP(-3%) TBT(-2%) ARKK(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.865% (StdDev 1.73%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $759.29 | 5 Day Moving Average | $753.36(-0.3%) | 10 Day Moving Average | $753.81(-0.36%) | 20 Day Moving Average | $759.29(-1.07%) | To recent high | -4.3% | To recent low | 10.4% | Market Cap | $79.641b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |